[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2002234219A1 - Granular composition comprising an active compound and a cellulose ether and the use thereof - Google Patents

Granular composition comprising an active compound and a cellulose ether and the use thereof

Info

Publication number
AU2002234219A1
AU2002234219A1 AU2002234219A AU2002234219A AU2002234219A1 AU 2002234219 A1 AU2002234219 A1 AU 2002234219A1 AU 2002234219 A AU2002234219 A AU 2002234219A AU 2002234219 A AU2002234219 A AU 2002234219A AU 2002234219 A1 AU2002234219 A1 AU 2002234219A1
Authority
AU
Australia
Prior art keywords
active compound
cellulose ether
granular composition
granular
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002234219A
Inventor
Tina P. Dasbach
Shawn A. Mitchell
Thomas D. Reynolds
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Global Technologies LLC
Original Assignee
Dow Global Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies LLC filed Critical Dow Global Technologies LLC
Publication of AU2002234219A1 publication Critical patent/AU2002234219A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002234219A 2001-03-09 2002-01-03 Granular composition comprising an active compound and a cellulose ether and the use thereof Abandoned AU2002234219A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27470801P 2001-03-09 2001-03-09
US60/274,708 2001-03-09
PCT/US2002/000264 WO2002072064A2 (en) 2001-03-09 2002-01-03 Granular composition comprising an active compound and a cellulose ether and the use thereof

Publications (1)

Publication Number Publication Date
AU2002234219A1 true AU2002234219A1 (en) 2002-09-24

Family

ID=23049301

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002234219A Abandoned AU2002234219A1 (en) 2001-03-09 2002-01-03 Granular composition comprising an active compound and a cellulose ether and the use thereof

Country Status (2)

Country Link
AU (1) AU2002234219A1 (en)
WO (1) WO2002072064A2 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
GB8722306D0 (en) * 1987-09-22 1987-10-28 Aps Research Ltd Sustained-release formulation
US4973470A (en) * 1989-06-26 1990-11-27 Warner-Lambert Company Sustained release pharmaceutical compositions
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US6045829A (en) * 1997-02-13 2000-04-04 Elan Pharma International Limited Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
DE10029201A1 (en) * 2000-06-19 2001-12-20 Basf Ag Retarded release oral dosage form, obtained by granulating mixture containing active agent and polyvinyl acetate-polyvinyl pyrrolidone mixture below the melting temperature

Also Published As

Publication number Publication date
WO2002072064A2 (en) 2002-09-19
WO2002072064A3 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
AU2001267860A1 (en) Cellulose powder
AU7595500A (en) Chemically active filter material
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU2002327096A1 (en) 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
AU2002349705A1 (en) Azole compound and medicinal use thereof
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001283107A1 (en) Powdered/microfibrillated cellulose
AU2001277526A1 (en) Substituted benzo-nitro-heterocycles and use thereof as herbicides
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2001289654A1 (en) Herbicide agent
AU2002221884A1 (en) Delta 1-pyrrolines used as pesticides
EP1151667A3 (en) Plant-activating agent
AU2002354410A1 (en) Triazole compound and medicinal use thereof
AU6737800A (en) Polymer for chemically amplified resist and a resist composition using the same
AU2002349882A1 (en) Q4n2neg2 enhances cftr activity
AU2001258792A1 (en) Insecticides
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU4432001A (en) Trityl-type compounds and their use
AU2001232075A1 (en) Compound, composition and use
AUPR099200A0 (en) New formulation
AU6325200A (en) Stable biocidal compositions
AU2001232080A1 (en) Compound, compositions and use
AU2002234219A1 (en) Granular composition comprising an active compound and a cellulose ether and the use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase